Delivery Order SPE2DB25D3017-SPE2DB26FVGRN
- Not listed
- The Defense Logistics Agency awarded a $5,869.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on November 4, 2025, with completion expected by November 5, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively made with no set-aside...
- The Defense Logistics Agency awarded a $3,313.05 delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 gm) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a $5,298.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12 gram units) on July 22, 2025, with completion expected by July 23, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The IDC serves as a...
- The Defense Logistics Agency awarded a $2,646.36 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm), with an ultimate completion date of June 13, 2025. This competitive award—utilizing firm fixed pricing with no set-aside designation—represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,775.70 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on May 8, 2025, with an ultimate completion date of May 9, 2025. This firm fixed-price delivery order represents a non-competitive award and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,549.84 to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, for the provision of Advair HFA 230-21 MCG Inhaler 12GM. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to supply a comprehensive range of pharmaceutical products and medical supplies to military...
- The Defense Logistics Agency awarded a $19,014.36 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $4,403.25. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to conclude by August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $4,299.37 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12gm) on October 28, 2025, with completion scheduled for October 29, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement supporting federal medical supply needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB26FVGRNDelivery Order
The Defense Logistics Agency (DLA) awarded a $7,379.04 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12gm) on October 17, 2025, with completion targeted for October 20, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively to the pharmaceutical distributor's Corporate Office division. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with an extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency and the Medical Supply Chain. The company's federal contract awards demonstrate capability across diverse therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for respiratory medication supports military healthcare requirements and reflects the vendor's consistent performance under competitively awarded, firm fixed-price delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 10/17/25 |